Abstract
This mini-review gives a structural view on the lipopolysaccharides (LPSs), the endotoxin from Gram negative bacteria, paying attention on the features that are relevant for their activity as elicitors of the innate immune system of humans, animals and plants.
Keywords: Endotoxin, innate immunity, lipid A, LPS, PAMP, PRR, Gram negative bacteria, immune system, lipid bilayer, hydrophilic compounds
Protein & Peptide Letters
Title:Bacterial Lipopolysaccharides in Plant and Mammalian Innate Immunity
Volume: 19 Issue: 10
Author(s): Cristina De Castro, Otto Holst, Rosa Lanzetta, Michelangelo Parrilli and Antonio Molinaro
Affiliation:
Keywords: Endotoxin, innate immunity, lipid A, LPS, PAMP, PRR, Gram negative bacteria, immune system, lipid bilayer, hydrophilic compounds
Abstract: This mini-review gives a structural view on the lipopolysaccharides (LPSs), the endotoxin from Gram negative bacteria, paying attention on the features that are relevant for their activity as elicitors of the innate immune system of humans, animals and plants.
Export Options
About this article
Cite this article as:
De Castro Cristina, Holst Otto, Lanzetta Rosa, Parrilli Michelangelo and Molinaro Antonio, Bacterial Lipopolysaccharides in Plant and Mammalian Innate Immunity, Protein & Peptide Letters 2012; 19 (10) . https://dx.doi.org/10.2174/092986612802762714
DOI https://dx.doi.org/10.2174/092986612802762714 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic:Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) (Guest Editor: Christopher J. Burns)]
Current Medicinal Chemistry - Anti-Infective Agents Safety Concerns Related to Hematopoietic Stem Cell Gene Transfer Using Retroviral Vectors
Current Gene Therapy Lysosomal Storage Diseases and the Blood-Brain Barrier
Current Pharmaceutical Design Asymptomatic Primary Hyperparathyroidism: Management and Implications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Adiponectin: An Endothelium-Derived Vasoprotective Factor?
Current Vascular Pharmacology Are the Extracelluar Pathways a Conduit for the Delivery of Therapeutics to the Brain?
Current Pharmaceutical Design Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury
Current Alzheimer Research Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
Current Drug Targets Protecting Skin Photoaging by NF-κB Inhibitor
Current Drug Metabolism KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Leber's Hereditary Optic Neuropathy: Novel Views and Persisting Challenges
CNS & Neurological Disorders - Drug Targets Mesenchymal Stromal Cells in Rheumatoid Arthritis: Biological Properties and Clinical Applications
Current Stem Cell Research & Therapy Recombinant Expression Systems for Allergen Vaccines
Inflammation & Allergy - Drug Targets (Discontinued) New Insights into Redox-Modulated Cell Signaling
Current Pharmaceutical Design Oral Tolerance Induction for Human Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma
Current Pharmaceutical Design Ectopic Lymphoid Neogenesis and Lymphoid Chemokines in Sjogren’s Syndrome: At the Interplay between Chronic Inflammation, Autoimmunity and Lymphomagenesis
Current Pharmaceutical Biotechnology Osteoblast Differentiation and Control by Vitamin D and Vitamin D Metabolites
Current Pharmaceutical Design Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Selective PGHS-2 Inhibitors: A Rational Approach for Treatment of the Inflammation
Medicinal Chemistry Reviews - Online (Discontinued)